# A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers

> **NCT02202187** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (actual)

## Conditions studied

- Infections, Respiratory Tract

## Interventions

- **DRUG:** GSK2140944
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02202187
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09-26
- **Primary completion:** 2012-02-15
- **Final completion:** 2012-02-15
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202187, "A Single Oral Escalating Dose Study of GSK2140944 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02202187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*